Figure 7. Inhibition of tumor growth by Taxol®, PTX-VE/VE/VE2-PEG2000/water and PTX-S-S-VE/VE/VE2-PEG2000/water NES in KB-3-1 cell subcutaneous xenografts.
The formulations were administered intravenously at an equivalent dose of 5 mg/kg of PTX every second day for 5 injections in total (data are expressed as the mean ± SD, n = 5 mice for each formulation) (p < 0.05 [*] and p < 0.01 [**]).